Hyperfine Inc (HYPR) SEC News Jan. 12, 2026, 13:28 UTC 2 1 comments (80% Positive) Hyperfine Inc (HYPR) Reports Q1 2026 Financial Results Comment Full text
Senseonics Holdings Inc. (SENS) SEC News Jan. 12, 2026, 13:25 UTC 2 1 comments (80% Positive) Senseonics Holdings Inc. (SENS) Reports Q1 2026 Financial Results Comment Full text
Mind Medicine (MNMD) SEC News Jan. 12, 2026, 13:24 UTC 2 1 comments (75% Positive) Mind Medicine (MNMD) Provides Update on paradigm for psychiatric drug development Comment Full text
Recursion Pharmaceuticals Inc (RXRX) SEC News Jan. 12, 2026, 13:21 UTC 2 1 comments (85% Positive) Recursion Pharmaceuticals Inc (RXRX) Files Form 8-K Comment Full text
ADMA Biologics Inc (ADMA) SEC News Jan. 12, 2026, 13:20 UTC 4 1 comments (85% Positive) ADMA Biologics Inc (ADMA) Reports Q1 2026 Financial Results Comment Full text
Harmony Biosciences (HRMY) SEC News Jan. 12, 2026, 13:20 UTC 4 1 comments (10% Negative) Harmony Biosciences (HRMY) Announces Delay in Trials Trials for San Francisco Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Perspective Therapeutics Inc (CATX) SEC News Jan. 12, 2026, 13:20 UTC 3 1 comments (99% Positive) Perspective Therapeutics Inc (CATX) Announces Enrollment Update for treatments Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Fulcrum Therapeutics (FULC) SEC News Jan. 12, 2026, 13:18 UTC 4 1 comments (85% Positive) Fulcrum Therapeutics (FULC) Files Form 8-K Comment Full text
Bionano Genomics Inc (BNGO) SEC News Jan. 12, 2026, 13:15 UTC 3 1 comments (99% Positive) Bionano Genomics Inc (BNGO) Reports Q1 2026 Financial Results Comment Full text
Adaptive Biotechnologies (ADPT) SEC News Jan. 12, 2026, 13:15 UTC 2 1 comments (99% Positive) Adaptive Biotechnologies (ADPT) Reports Q1 2026 Financial Results Comment Full text
Rigel Pharmaceuticals Inc (RIGL) SEC News Jan. 12, 2026, 13:15 UTC 3 1 comments (90% Positive) Rigel Pharmaceuticals Inc (RIGL) Announces Enrollment Update for year Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Twist Bioscience (TWST) SEC News Jan. 12, 2026, 13:13 UTC 3 1 comments (10% Negative) Twist Bioscience (TWST) Reports Q1 2026 Financial Results Comment Full text
Progyny Inc (PGNY) SEC News Jan. 12, 2026, 13:12 UTC 4 1 comments (99% Neutral) Progyny Inc (PGNY) Reports Q1 2026 Financial Results Comment Full text
Achieve Life Sciences Inc. (ACHV) SEC News Jan. 12, 2026, 13:10 UTC 8 0 comments New Form 3 - ACHIEVE LIFE SCIENCES, INC. Filed: 2026-01-12 AccNo: 0001193125-26-009831 Size: 20 KB Comment Full text
CVRx Inc. (CVRX) SEC News Jan. 12, 2026, 13:10 UTC 3 1 comments (80% Positive) CVRx Inc. (CVRX) Reports Q1 2026 Financial Results Comment Full text